Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Experimental Pharmacology"
DOI: 10.2147/jep.s259330
Abstract: Introduction Bronchodilators are the cornerstone of chronic obstructive pulmonary disease (COPD) therapy and long-acting muscarinic antagonists (LAMAs) as a mono or combination treatment play a pivotal role. Several LAMAs are already available on the market… read more here.
Keywords: chronic obstructive; acting muscarinic; muscarinic antagonists; long acting ... See more keywords